Related Experiment Videos
Combined effects of noise and kanamycin. Cochlear pathology and pharmacology
Abstract:
Concurrent administration of aminoglycoside antibiotics and acoustic exposure is reported to result in a cochlear damage level exceeding that predicted from the effects of either agent given alone. To investigate this interaction, guinea pigs were given daily subcutaneous injections of kanamycin sulfate at 200, 300, or 400 mg/kg followed by a ten-hour noise exposure (115 or 45 dB) for seven consecutive days. Drug levels in plasma and perilymph were measured during the 24 hours after injection and during the seven-day period of drug and noise exposures. Electrophysiological and morphological evaluation of cochlear function confirmed a dramatic interaction at the 300-mg/kg dosage. Augmentation of damage was minimal at 200 mg/kg and masked by ceiling effects at 400 mg/kg. No alteration in accumulation or elimination of kanamycin occurred as a result of high-intensity acoustic exposure.
Insights
Aminoglycoside antibiotics like kanamycin and noise exposure can cause synergistic cochlear damage. A 300 mg/kg kanamycin dose combined with noise significantly amplified hearing loss in guinea pigs.
Area of Science:
- Ototoxicity research
- Auditory science
- Pharmacology
Background:
- Concurrent exposure to aminoglycoside antibiotics and acoustic stimuli can lead to greater cochlear damage than predicted by individual exposures.
- Understanding this interaction is crucial for preventing hearing loss.
Purpose of the Study:
- To investigate the interaction between kanamycin sulfate and acoustic exposure on cochlear function in guinea pigs.
- To determine the dose-dependent effects of kanamycin on noise-induced ototoxicity.
Main Methods:
- Guinea pigs received daily subcutaneous injections of kanamycin sulfate (200, 300, or 400 mg/kg) for seven days.
- Animals were concurrently exposed to noise (115 or 45 dB) for ten hours daily.
- Kanamycin levels in plasma and perilymph were measured, and cochlear function was assessed electrophysiologically and morphologically.
Main Results:
- A significant synergistic ototoxic interaction was observed at the 300 mg/kg kanamycin dosage.
- Minimal additional damage was noted at 200 mg/kg, while higher doses showed ceiling effects.
- Acoustic exposure did not alter kanamycin accumulation or elimination.
Conclusions:
- Kanamycin sulfate and acoustic exposure exhibit a dose-dependent synergistic ototoxic effect, most pronounced at 300 mg/kg.
- This interaction can lead to severe cochlear damage, highlighting the risks of combined exposure.
- Further research is needed to elucidate the mechanisms underlying this synergistic ototoxicity.